PCA
IRWD icon

Pallas Capital Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Pallas Capital Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$312K Sell
73,996
-6,571
-8% -$25.3K 0.01% 724
2026
Q1 		$283K Sell
80,567
-7,408
-8% -$30.4K 0.01% 653
2025
Q4 		$296K Buy
87,975
+406
+0.5% +$1.05K 0.01% 679
2025
Q3 		$115K Buy
87,569
+8,057
+10% +$8.34K ﹤0.01% 824
2025
Q2 		$57K Buy
79,512
+65,172
+454% +$51.2K ﹤0.01% 819
2025
Q1 		$21.1K Buy
+14,340
New +$34.2K ﹤0.01% 741

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Pallas Capital Advisors's IRWD Position: Q2 2026 in Review

Pallas Capital Advisors reduced its Ironwood Pharmaceuticals (IRWD) stake by 8.2% in Q2 2026, selling an estimated $25.3K and leaving 73,996 shares worth $312K. The position accounts for 0.01% of the portfolio, ranked #724.

Pallas Capital Advisors first reported a position in IRWD in Q1 2025 and has held it in 6 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Pallas Capital Advisors held 73,996 shares of Ironwood Pharmaceuticals worth $312K as of Q2 2026.
  • Pallas Capital Advisors sold 6,571 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $25.3K.
  • Ironwood Pharmaceuticals made up 0.01% of Pallas Capital Advisors's portfolio in Q2 2026, its #724 holding.
  • Pallas Capital Advisors first reported a position in Ironwood Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.